AKI Prevention and Early Intervention in VAD Patients Admitted for Acute Medical Events

Overview

About this study

The investigators are doing this research to investigate whether multifaceted preventive measures for newly hospitalized ventricular assist device (VAD) patients will reduce the Acute Kidney Injury (AKI) occurrence rate, progression and associated complications

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients with VAD in place who are admitted to the hospital for acute medical illness during the study period.
- For those with multiple admissions during the study period only the first admission will be studied.
Patients who are able to give consent.
- In case of patients that are mentally impaired we will obtain consent from power of attorney and when patients regain intact mental capacity we will reobtain consent from the patient.

Exclusion Criteria:

Patients on dialysis (hemodialysis or peritoneal dialysis).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Qi Qian, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Qi Qian, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials